Loading…

In vivo potentiation of concanavalin A-bound L1210 vaccine by antimacrophage agents

Carrageenan potentiated in vivo the primary and secondary responses by concanavalin A (Con A)-bound L1210 murine leukemia vaccine and induced in histocompatible animals enhanced immune resistance to subsequent inoculations of live L1210 cells. This enhancement was critically dependent on the vaccine...

Full description

Saved in:
Bibliographic Details
Published in:Cancer research (Chicago, Ill.) Ill.), 1980-10, Vol.40 (10), p.3832-3838
Main Authors: Kataoka, T, Oh-hashi, F, Sakurai, Y, Gomi, K
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 3838
container_issue 10
container_start_page 3832
container_title Cancer research (Chicago, Ill.)
container_volume 40
creator Kataoka, T
Oh-hashi, F
Sakurai, Y
Gomi, K
description Carrageenan potentiated in vivo the primary and secondary responses by concanavalin A (Con A)-bound L1210 murine leukemia vaccine and induced in histocompatible animals enhanced immune resistance to subsequent inoculations of live L1210 cells. This enhancement was critically dependent on the vaccine preparation and the administration timing of carrageenan. Carrageenan potentiated Con A-free vaccine to a much lesser extent if at all, than did Con A-bound vaccine, and it was effective only on the day of or one day after vaccine administration. This enhancement was L1210 specific as evidenced by the lethal growth of P388 leukemia cells in animals inoculated with Con A-bound L1210 vaccine and carrageenan. This is explicable by the increase of spleen but not peritoneal exudate effector cells as measured by suppression of in vitro L1210 cell growth. The following findings suggested that potentiation of Con A-bound vaccine by carrageenan was achieved by affecting suppressor macrophages. Silica and trypan blue, other antimacrophage agents, potentiated Con A-bound vaccine. The enhancement was nullified by the macrophage-stabilizing agent, poly-2-vinylpyridine N-oxide. This hypothesis was further evidenced by the following findings. Phagocytic peritoneal cells induced by Con A-bound vaccine and adhering to the plastic vessel suppressed in vitro spleen cell blastogenesis. Antimacrophage agents abrogated not only production but also activity of these suppressor cells. The combined administration of Con A-bound L1210 vaccine and carrageenan produced an enhanced antitumor immune response and prolonged the life span of tumor-bearing animals marginally but significantly.
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_75347678</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>75347678</sourcerecordid><originalsourceid>FETCH-LOGICAL-h155t-8fc14f6afe470395d18b903d8678e1299fd2d2195324f3f22bfe78c2a08785ed3</originalsourceid><addsrcrecordid>eNotUMtqwzAA82Gj67p9wsCn3QJ-xs6xlD0KgR62nYPjx-qR2FnsBPr3M6wHIQSSELoBW4SQrDgT5A7cp_RTJMeIb8CmJpzVjGzBxzHA1a8RTjHbkL3KPgYYHdQxaBXUqgYf4L7q4xIMbDHBCK5Kax8s7C9Qlcio9Byns_q2sCDk9ABunRqSfbzyDny9vnwe3qv29HY87NvqjDnPlXQaM1crZ5lAtOEGy75B1MhaSItJ0zhDDMENp4Q56gjpnRVSE4WkkNwaugPP_73THH8Xm3I3-qTtMKhg45I6wSkTpawYn67GpR-t6aa5jJ4v3fUF-geIFVcD</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75347678</pqid></control><display><type>article</type><title>In vivo potentiation of concanavalin A-bound L1210 vaccine by antimacrophage agents</title><source>EZB Free E-Journals</source><creator>Kataoka, T ; Oh-hashi, F ; Sakurai, Y ; Gomi, K</creator><creatorcontrib>Kataoka, T ; Oh-hashi, F ; Sakurai, Y ; Gomi, K</creatorcontrib><description>Carrageenan potentiated in vivo the primary and secondary responses by concanavalin A (Con A)-bound L1210 murine leukemia vaccine and induced in histocompatible animals enhanced immune resistance to subsequent inoculations of live L1210 cells. This enhancement was critically dependent on the vaccine preparation and the administration timing of carrageenan. Carrageenan potentiated Con A-free vaccine to a much lesser extent if at all, than did Con A-bound vaccine, and it was effective only on the day of or one day after vaccine administration. This enhancement was L1210 specific as evidenced by the lethal growth of P388 leukemia cells in animals inoculated with Con A-bound L1210 vaccine and carrageenan. This is explicable by the increase of spleen but not peritoneal exudate effector cells as measured by suppression of in vitro L1210 cell growth. The following findings suggested that potentiation of Con A-bound vaccine by carrageenan was achieved by affecting suppressor macrophages. Silica and trypan blue, other antimacrophage agents, potentiated Con A-bound vaccine. The enhancement was nullified by the macrophage-stabilizing agent, poly-2-vinylpyridine N-oxide. This hypothesis was further evidenced by the following findings. Phagocytic peritoneal cells induced by Con A-bound vaccine and adhering to the plastic vessel suppressed in vitro spleen cell blastogenesis. Antimacrophage agents abrogated not only production but also activity of these suppressor cells. The combined administration of Con A-bound L1210 vaccine and carrageenan produced an enhanced antitumor immune response and prolonged the life span of tumor-bearing animals marginally but significantly.</description><identifier>ISSN: 0008-5472</identifier><identifier>PMID: 6254642</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Antigen-Antibody Complex ; Carrageenan - immunology ; Carrageenan - pharmacology ; Concanavalin A - immunology ; Immunization ; Immunotherapy ; Leukemia L1210 - immunology ; Leukemia L1210 - prevention &amp; control ; Macrophages - drug effects ; Macrophages - immunology ; Male ; Mice ; Polyvinylpyridine N-Oxide - pharmacology ; Prognosis ; Silicon Dioxide - pharmacology ; T-Lymphocytes, Regulatory ; Trypan Blue - pharmacology ; Vaccines - administration &amp; dosage ; Vaccines - immunology</subject><ispartof>Cancer research (Chicago, Ill.), 1980-10, Vol.40 (10), p.3832-3838</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6254642$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kataoka, T</creatorcontrib><creatorcontrib>Oh-hashi, F</creatorcontrib><creatorcontrib>Sakurai, Y</creatorcontrib><creatorcontrib>Gomi, K</creatorcontrib><title>In vivo potentiation of concanavalin A-bound L1210 vaccine by antimacrophage agents</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>Carrageenan potentiated in vivo the primary and secondary responses by concanavalin A (Con A)-bound L1210 murine leukemia vaccine and induced in histocompatible animals enhanced immune resistance to subsequent inoculations of live L1210 cells. This enhancement was critically dependent on the vaccine preparation and the administration timing of carrageenan. Carrageenan potentiated Con A-free vaccine to a much lesser extent if at all, than did Con A-bound vaccine, and it was effective only on the day of or one day after vaccine administration. This enhancement was L1210 specific as evidenced by the lethal growth of P388 leukemia cells in animals inoculated with Con A-bound L1210 vaccine and carrageenan. This is explicable by the increase of spleen but not peritoneal exudate effector cells as measured by suppression of in vitro L1210 cell growth. The following findings suggested that potentiation of Con A-bound vaccine by carrageenan was achieved by affecting suppressor macrophages. Silica and trypan blue, other antimacrophage agents, potentiated Con A-bound vaccine. The enhancement was nullified by the macrophage-stabilizing agent, poly-2-vinylpyridine N-oxide. This hypothesis was further evidenced by the following findings. Phagocytic peritoneal cells induced by Con A-bound vaccine and adhering to the plastic vessel suppressed in vitro spleen cell blastogenesis. Antimacrophage agents abrogated not only production but also activity of these suppressor cells. The combined administration of Con A-bound L1210 vaccine and carrageenan produced an enhanced antitumor immune response and prolonged the life span of tumor-bearing animals marginally but significantly.</description><subject>Animals</subject><subject>Antigen-Antibody Complex</subject><subject>Carrageenan - immunology</subject><subject>Carrageenan - pharmacology</subject><subject>Concanavalin A - immunology</subject><subject>Immunization</subject><subject>Immunotherapy</subject><subject>Leukemia L1210 - immunology</subject><subject>Leukemia L1210 - prevention &amp; control</subject><subject>Macrophages - drug effects</subject><subject>Macrophages - immunology</subject><subject>Male</subject><subject>Mice</subject><subject>Polyvinylpyridine N-Oxide - pharmacology</subject><subject>Prognosis</subject><subject>Silicon Dioxide - pharmacology</subject><subject>T-Lymphocytes, Regulatory</subject><subject>Trypan Blue - pharmacology</subject><subject>Vaccines - administration &amp; dosage</subject><subject>Vaccines - immunology</subject><issn>0008-5472</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1980</creationdate><recordtype>article</recordtype><recordid>eNotUMtqwzAA82Gj67p9wsCn3QJ-xs6xlD0KgR62nYPjx-qR2FnsBPr3M6wHIQSSELoBW4SQrDgT5A7cp_RTJMeIb8CmJpzVjGzBxzHA1a8RTjHbkL3KPgYYHdQxaBXUqgYf4L7q4xIMbDHBCK5Kax8s7C9Qlcio9Byns_q2sCDk9ABunRqSfbzyDny9vnwe3qv29HY87NvqjDnPlXQaM1crZ5lAtOEGy75B1MhaSItJ0zhDDMENp4Q56gjpnRVSE4WkkNwaugPP_73THH8Xm3I3-qTtMKhg45I6wSkTpawYn67GpR-t6aa5jJ4v3fUF-geIFVcD</recordid><startdate>198010</startdate><enddate>198010</enddate><creator>Kataoka, T</creator><creator>Oh-hashi, F</creator><creator>Sakurai, Y</creator><creator>Gomi, K</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>198010</creationdate><title>In vivo potentiation of concanavalin A-bound L1210 vaccine by antimacrophage agents</title><author>Kataoka, T ; Oh-hashi, F ; Sakurai, Y ; Gomi, K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h155t-8fc14f6afe470395d18b903d8678e1299fd2d2195324f3f22bfe78c2a08785ed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1980</creationdate><topic>Animals</topic><topic>Antigen-Antibody Complex</topic><topic>Carrageenan - immunology</topic><topic>Carrageenan - pharmacology</topic><topic>Concanavalin A - immunology</topic><topic>Immunization</topic><topic>Immunotherapy</topic><topic>Leukemia L1210 - immunology</topic><topic>Leukemia L1210 - prevention &amp; control</topic><topic>Macrophages - drug effects</topic><topic>Macrophages - immunology</topic><topic>Male</topic><topic>Mice</topic><topic>Polyvinylpyridine N-Oxide - pharmacology</topic><topic>Prognosis</topic><topic>Silicon Dioxide - pharmacology</topic><topic>T-Lymphocytes, Regulatory</topic><topic>Trypan Blue - pharmacology</topic><topic>Vaccines - administration &amp; dosage</topic><topic>Vaccines - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kataoka, T</creatorcontrib><creatorcontrib>Oh-hashi, F</creatorcontrib><creatorcontrib>Sakurai, Y</creatorcontrib><creatorcontrib>Gomi, K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kataoka, T</au><au>Oh-hashi, F</au><au>Sakurai, Y</au><au>Gomi, K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vivo potentiation of concanavalin A-bound L1210 vaccine by antimacrophage agents</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>1980-10</date><risdate>1980</risdate><volume>40</volume><issue>10</issue><spage>3832</spage><epage>3838</epage><pages>3832-3838</pages><issn>0008-5472</issn><abstract>Carrageenan potentiated in vivo the primary and secondary responses by concanavalin A (Con A)-bound L1210 murine leukemia vaccine and induced in histocompatible animals enhanced immune resistance to subsequent inoculations of live L1210 cells. This enhancement was critically dependent on the vaccine preparation and the administration timing of carrageenan. Carrageenan potentiated Con A-free vaccine to a much lesser extent if at all, than did Con A-bound vaccine, and it was effective only on the day of or one day after vaccine administration. This enhancement was L1210 specific as evidenced by the lethal growth of P388 leukemia cells in animals inoculated with Con A-bound L1210 vaccine and carrageenan. This is explicable by the increase of spleen but not peritoneal exudate effector cells as measured by suppression of in vitro L1210 cell growth. The following findings suggested that potentiation of Con A-bound vaccine by carrageenan was achieved by affecting suppressor macrophages. Silica and trypan blue, other antimacrophage agents, potentiated Con A-bound vaccine. The enhancement was nullified by the macrophage-stabilizing agent, poly-2-vinylpyridine N-oxide. This hypothesis was further evidenced by the following findings. Phagocytic peritoneal cells induced by Con A-bound vaccine and adhering to the plastic vessel suppressed in vitro spleen cell blastogenesis. Antimacrophage agents abrogated not only production but also activity of these suppressor cells. The combined administration of Con A-bound L1210 vaccine and carrageenan produced an enhanced antitumor immune response and prolonged the life span of tumor-bearing animals marginally but significantly.</abstract><cop>United States</cop><pmid>6254642</pmid><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-5472
ispartof Cancer research (Chicago, Ill.), 1980-10, Vol.40 (10), p.3832-3838
issn 0008-5472
language eng
recordid cdi_proquest_miscellaneous_75347678
source EZB Free E-Journals
subjects Animals
Antigen-Antibody Complex
Carrageenan - immunology
Carrageenan - pharmacology
Concanavalin A - immunology
Immunization
Immunotherapy
Leukemia L1210 - immunology
Leukemia L1210 - prevention & control
Macrophages - drug effects
Macrophages - immunology
Male
Mice
Polyvinylpyridine N-Oxide - pharmacology
Prognosis
Silicon Dioxide - pharmacology
T-Lymphocytes, Regulatory
Trypan Blue - pharmacology
Vaccines - administration & dosage
Vaccines - immunology
title In vivo potentiation of concanavalin A-bound L1210 vaccine by antimacrophage agents
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T21%3A39%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vivo%20potentiation%20of%20concanavalin%20A-bound%20L1210%20vaccine%20by%20antimacrophage%20agents&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=Kataoka,%20T&rft.date=1980-10&rft.volume=40&rft.issue=10&rft.spage=3832&rft.epage=3838&rft.pages=3832-3838&rft.issn=0008-5472&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E75347678%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-h155t-8fc14f6afe470395d18b903d8678e1299fd2d2195324f3f22bfe78c2a08785ed3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=75347678&rft_id=info:pmid/6254642&rfr_iscdi=true